The project clearly aims to translate genetic data into clinical applications. The integration of over eighty thousand scans from six hundred thousand individuals suggests a robust analytical framework. It seems well-positioned to identify susceptibility genes, though the specific diagnostic indicators mentioned are not fully detailed in the summary text.
Questions about ::ENGAGE:: EUROPEAN NETWORK OF GENETIC AND GENOMIC EPIDEMIOLOGY
What is ::ENGAGE:: EUROPEAN NETWORK OF GENETIC AND GENOMIC EPIDEMIOLOGY?
::ENGAGE:: is a European research project funded by the European Commission under the 7th Framework Programme-Health Theme. It integrates and analyzes large-scale human genetics datasets, including over 80,000 genome-wide association scans and samples from more than 600,000 individuals. The consortium aims to identify novel susceptibility genes influencing metabolic, behavioral, and cardiovascular traits.
What are the stated terms or policies for using the ENGAGE network?
The project operates as a research initiative rather than a commercial service, so it does not offer standard customer-facing terms like delivery, returns, or cancellation policies. Instead, its core function is to translate data from population cohorts into information relevant for future clinical applications. The consortium focuses on identifying genes that affect disease risk and treatment responses.
Who exactly does the ENGAGE network suit and who does it not?
The network is designed for European researchers and medical professionals who need to analyze large-scale genetic data. It specifically targets those interested in metabolic, behavioral, and cardiovascular traits. The consortium brings together 24 leading research organizations and two biotechnology and pharmaceutical companies across Europe, Canada, and Australia.
How long has the project existed and what is its current rating?
The project has been active since January 1st, 2008, with a planned duration of five years under its initial funding period. It currently holds a Trustburn rating of 4.2 out of 5 based on 5 reviews. The consortium is composed of 24 research organizations and two biotech/pharma companies from multiple countries.
What specific products or services does the ENGAGE network provide?
The network's primary feature is its massive dataset, which includes over 80,000 genome-wide association scans and DNA/serum/plasma samples from over 600,000 individuals. This data allows the consortium to study interactions between genes and lifestyle factors. The project also provides access to an archive of news and publications for researchers.
What are the main objectives and goals of the ENGAGE project?
The consortium aims to demonstrate that its findings can serve as diagnostic indicators for common diseases. This includes helping to understand risk factors, disease progression, and why people differ in their responses to treatment. The project also offers training and resources for young investigators through its members area.
How does the ENGAGE network operate and who are its partners?
The network operates by integrating and analyzing data from European and other population cohorts. It functions as a research project funded by the European Commission under the 7th Framework Programme-Health Theme. The consortium includes partners from Europe, Canada, and Australia working together on this initiative.
What is the history and funding background of the ENGAGE project?
The project's history began in 2008 with a 12 million euro grant from the European Commission. It has since produced an executive summary and a final publishable summary report covering the period from 2008 to 2012. The consortium continues to work on translating genetic data into clinical applications.
What additional resources or tools does the ENGAGE network offer?
The network's website mentions that it provides resources and a members area for its partners. It also hosts a video and an archive of news and publications for public access. The project encourages collaboration among researchers across different countries to achieve its scientific goals.
How does the ENGAGE network measure its success and impact?
The project's success is measured by its ability to identify novel susceptibility genes and study gene-lifestyle interactions. It aims to translate these findings into diagnostic indicators for common diseases. The consortium's work is supported by a diverse group of research organizations and industry partners.
What is the official website of ::ENGAGE:: EUROPEAN NETWORK OF GENETIC AND GENOMIC EPIDEMIOLOGY?
The official website of ::ENGAGE:: EUROPEAN NETWORK OF GENETIC AND GENOMIC EPIDEMIOLOGY is euengage.org.
AI-generated from reviews on this page. Verify anything important with the company directly.
The final publishable summary report is readily available for download, providing clear insight into the project's outcomes from 2008 to 2012.
The ENGAGE website serves as a useful repository for project summaries and partner lists. The description of the consortium's goals is clear and professional. However, the notice regarding the need for a newer Adobe Flash Player for video content is noticeable. Despite this minor technical hurdle, the availability of executive summaries and final reports indicates a commitment to transparency. The network’s focus on integrating large datasets seems well-executed, making it a valuable resource for researchers in genetic epidemiology.
From the information available, the scope of the ENGAGE consortium appears genuinely impressive, bringing together twenty-four research organizations alongside biotechnology and pharmaceutical entities across Europe, Canada, and Australia. The project’s aim to translate large-scale genetic data into clinical applications is well-articulated. What stands out is the sheer volume of data managed, with over eighty thousand genome-wide association scans and samples from more than six hundred thousand individuals. It seems reasonable to assume that such a robust infrastructure supports high-quality research outcomes. While the final reports are available for download, the detailed methodology might require further exploration to fully appreciate the depth of the analysis. The integration of these vast datasets suggests a strong collaborative effort. For someone considering this network for potential collaboration or data utilization, the structured approach to identifying susceptibility genes for metabolic and cardiovascular traits appears promising. The clear objective to understand disease progression and treatment response variations adds significant value to the field. It is a well-organized initiative that leverages substantial resources effectively.
The website provides a clear overview of the ENGAGE project, detailing its funding, partners, and objectives. It is informative for those interested in genetic epidemiology, though the reliance on Flash for video content is a minor technical drawback for modern browsers.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About ::ENGAGE:: EUROPEAN NETWORK OF GENETIC AND GENOMIC EPIDEMIOLOGY
::ENGAGE:: is a European network for genetic and genomic epidemiology that functions as a research project funded by the European Commission. The consortium integrates and analyzes large-scale human genetics datasets, including genome-wide association scans and samples from over 600,000 individuals. Its objectives include identifying novel susceptibility genes that influence metabolic, behavioral, and cardiovascular traits and studying interactions between genes and lifestyle factors. The network aims to translate research data into diagnostic indicators for common diseases to better understand risk factors and treatment responses.
- Website
- euengage.org
- Categories
- Research